메뉴 건너뛰기




Volumn 138, Issue 5, 2007, Pages 563-579

Immunodeficiency and immunotherapy in multiple myeloma

Author keywords

B cells; Immune; Infection; Myeloma; T cells

Indexed keywords

3 (4 AMINO 1,3 DIHYDRO 1,3 DIOXO 2H ISOINDOL 2 YL)GLUTARIMIDE; BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOOXYGENASE 2; FAS LIGAND; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 6; LENALIDOMIDE; LEVOFLOXACIN; MATRIX METALLOPROTEINASE; MUCIN 1; OFLOXACIN; PROSTANOID; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

EID: 34547677725     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06705.x     Document Type: Review
Times cited : (288)

References (176)
  • 1
    • 0031914321 scopus 로고    scopus 로고
    • Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
    • Agrawal, B., Krantz, M.J., Reddish, M.A. Longenecker, B.M. (1998) Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Medicine, 4, 43 49.
    • (1998) Nature Medicine , vol.4 , pp. 43-49
    • Agrawal, B.1    Krantz, M.J.2    Reddish, M.A.3    Longenecker, B.M.4
  • 4
    • 33644829447 scopus 로고    scopus 로고
    • Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party
    • Augustson, B.M., Begum, G., Dunn, J.A., Barth, N.J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J.A. Drayson, M.T. (2005) Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. Journal of Clinical Oncology, 23, 9219 9226.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 9219-9226
    • Augustson, B.M.1    Begum, G.2    Dunn, J.A.3    Barth, N.J.4    Davies, F.5    Morgan, G.6    Behrens, J.7    Smith, A.8    Child, J.A.9    Drayson, M.T.10
  • 5
    • 0028246112 scopus 로고
    • Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell
    • Bakkus, M.H.C., Van Riet, I., Van Camp, B. Thielemann, K. (1994) Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. British Journal of Haematology, 87, 68 74.
    • (1994) British Journal of Haematology , vol.87 , pp. 68-74
    • Bakkus, M.H.C.1    Van Riet, I.2    Van Camp, B.3    Thielemann, K.4
  • 6
    • 33750614944 scopus 로고    scopus 로고
    • Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after DC injection of cytokine matured DCs in myeloma patients
    • Banerjee, D., Dhodapkar, M.V., Matayeva, E., Steinman, R.M. Dhodapkar, K. (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after DC injection of cytokine matured DCs in myeloma patients. Blood, 108, 2655 2661.
    • (2006) Blood , vol.108 , pp. 2655-2661
    • Banerjee, D.1    Dhodapkar, M.V.2    Matayeva, E.3    Steinman, R.M.4    Dhodapkar, K.5
  • 7
    • 1942534043 scopus 로고    scopus 로고
    • The evolution of thalidomide and its IMiD derivatives as anticancer agents
    • Bartlett, J.B., Dredge, K. Dalgleish, A.G. (2004a) The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nature Reviews Cancer, 4, 314 322.
    • (2004) Nature Reviews Cancer , vol.4 , pp. 314-322
    • Bartlett, J.B.1    Dredge, K.2    Dalgleish, A.G.3
  • 12
    • 27244445489 scopus 로고    scopus 로고
    • Molecular pathogenesis and a consequent classification of multiple myeloma
    • Bergsagel, P.L. Kuehl, W.M. (2005) Molecular pathogenesis and a consequent classification of multiple myeloma. Journal of Clinical Oncology, 23, 6333 6338.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 6333-6338
    • Bergsagel, P.L.1    Kuehl, W.M.2
  • 13
    • 33646577466 scopus 로고    scopus 로고
    • Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    • Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L. Kuchroo, V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235 238.
    • (2006) Nature , vol.441 , pp. 235-238
    • Bettelli, E.1    Carrier, Y.2    Gao, W.3    Korn, T.4    Strom, T.B.5    Oukka, M.6    Weiner, H.L.7    Kuchroo, V.K.8
  • 14
    • 33746599842 scopus 로고    scopus 로고
    • Regulatory T cells in cancer
    • Beyer, M. Schultze, J.L. (2006) Regulatory T cells in cancer. Blood, 108, 804 811.
    • (2006) Blood , vol.108 , pp. 804-811
    • Beyer, M.1    Schultze, J.L.2
  • 15
    • 33646575622 scopus 로고    scopus 로고
    • In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
    • Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M.R., Knolle, P.A., Classen, S. Schultze, J.L. (2006) In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood, 107, 3940 3949.
    • (2006) Blood , vol.107 , pp. 3940-3949
    • Beyer, M.1    Kochanek, M.2    Giese, T.3    Endl, E.4    Weihrauch, M.R.5    Knolle, P.A.6    Classen, S.7    Schultze, J.L.8
  • 17
    • 0027257608 scopus 로고
    • The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell
    • Billadeau, D., Ahmann, G., Greipp, P. Van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. Journal of Experimental Medicine, 178, 1023 1031.
    • (1993) Journal of Experimental Medicine , vol.178 , pp. 1023-1031
    • Billadeau, D.1    Ahmann, G.2    Greipp, P.3    Van Ness, B.4
  • 19
    • 0029906983 scopus 로고    scopus 로고
    • Peripheral T cell tolerance as a tumor escape mechanism: Deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma
    • Bogen, B. (1996) Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. European Journal of Immunology, 26, 2671 2679.
    • (1996) European Journal of Immunology , vol.26 , pp. 2671-2679
    • Bogen, B.1
  • 22
    • 0037114695 scopus 로고    scopus 로고
    • Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma
    • Borson, N.D., Lacy, M.Q. Wettstein, P.J. (2002) Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood, 100, 4629 4639.
    • (2002) Blood , vol.100 , pp. 4629-4639
    • Borson, N.D.1    Lacy, M.Q.2    Wettstein, P.J.3
  • 23
    • 33645098467 scopus 로고    scopus 로고
    • Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma
    • Brimnes, M.K., Svane, I.M. Johnsen, H.E. (2006) Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma. Clinical and Experimental Immunology, 144, 76 84.
    • (2006) Clinical and Experimental Immunology , vol.144 , pp. 76-84
    • Brimnes, M.K.1    Svane, I.M.2    Johnsen, H.E.3
  • 24
    • 18444408375 scopus 로고    scopus 로고
    • COX-2: A molecular target for colorectal cancer prevention
    • Brown, J.R. DuBois, R.N. (2005) COX-2: a molecular target for colorectal cancer prevention. Journal of Clinical Oncology, 23, 2840 2855.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 2840-2855
    • Brown, J.R.1    Dubois, R.N.2
  • 25
    • 0030923576 scopus 로고    scopus 로고
    • The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma
    • Brown, R.D., Yuen, E., Nelson, M., Gibson, J. Joshua, D. (1997) The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma. Leukemia, 11, 1312 1317.
    • (1997) Leukemia , vol.11 , pp. 1312-1317
    • Brown, R.D.1    Yuen, E.2    Nelson, M.3    Gibson, J.4    Joshua, D.5
  • 26
    • 0032427590 scopus 로고    scopus 로고
    • The expression of T cell related costimulatory molecules in multiple myeloma
    • Brown, R.D., Pope, B., Yuen, E., Gibson, J. Joshua, D.E. (1998) The expression of T cell related costimulatory molecules in multiple myeloma. Leukemia and Lymphoma, 31, 379 384.
    • (1998) Leukemia and Lymphoma , vol.31 , pp. 379-384
    • Brown, R.D.1    Pope, B.2    Yuen, E.3    Gibson, J.4    Joshua, D.E.5
  • 27
    • 0035892109 scopus 로고    scopus 로고
    • Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10
    • Brown, R.D., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., Ho, P.J., Hart, D. Joshua, D. (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. Blood, 98, 2992 2998.
    • (2001) Blood , vol.98 , pp. 2992-2998
    • Brown, R.D.1    Pope, B.2    Murray, A.3    Esdale, W.4    Sze, D.M.5    Gibson, J.6    Ho, P.J.7    Hart, D.8    Joshua, D.9
  • 28
    • 3042691752 scopus 로고    scopus 로고
    • Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma
    • Brown, R., Murray, A., Pope, B., Sze, D.m., Gibson, J., Ho, P.J., Hart, D. Joshua, D. (2004) Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma. British Journal of Haematology, 125, 743 748.
    • (2004) British Journal of Haematology , vol.125 , pp. 743-748
    • Brown, R.1    Murray, A.2    Pope, B.3    Sze, D.M.4    Gibson, J.5    Ho, P.J.6    Hart, D.7    Joshua, D.8
  • 31
    • 0035399605 scopus 로고    scopus 로고
    • Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15
    • Campbell, J.D., Cook, G., Robertson, S.E., Fraser, A., Gracie, J.A. Franklin, I.M. (2001) Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. Journal of Immunology, 167, 553 561.
    • (2001) Journal of Immunology , vol.167 , pp. 553-561
    • Campbell, J.D.1    Cook, G.2    Robertson, S.E.3    Fraser, A.4    Gracie, J.A.5    Franklin, I.M.6
  • 33
    • 22544457164 scopus 로고    scopus 로고
    • Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
    • Carlos, C.A., Dong, H.F., Howard, O.M., Oppenheim, J.J., Hanisch, F.G. Finn, O.J. (2005) Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. Journal of Immunology, 175, 1628 1635.
    • (2005) Journal of Immunology , vol.175 , pp. 1628-1635
    • Carlos, C.A.1    Dong, H.F.2    Howard, O.M.3    Oppenheim, J.J.4    Hanisch, F.G.5    Finn, O.J.6
  • 34
    • 33745961875 scopus 로고    scopus 로고
    • Enhancement of ligand dependent activation of human natural killer T cells by lenalidomide: Therapeutic implications
    • Chang, D.H., Liu, N., Klimek, V., Hassoun, H., Mazumder, A., Nimer, S.D., Jagannath, S. Dhodapkar, M.V. (2006) Enhancement of ligand dependent activation of human natural killer T cells by lenalidomide: therapeutic implications. Blood, 108, 618 621.
    • (2006) Blood , vol.108 , pp. 618-621
    • Chang, D.H.1    Liu, N.2    Klimek, V.3    Hassoun, H.4    Mazumder, A.5    Nimer, S.D.6    Jagannath, S.7    Dhodapkar, M.V.8
  • 35
    • 0028230488 scopus 로고
    • Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. the UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma
    • Chapel, H.M., Lee, M., Hargreaves, R., Pamphilon, D.H. Prentice, A.G. (1994) Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma. Lancet, 343, 1059 1063.
    • (1994) Lancet , vol.343 , pp. 1059-1063
    • Chapel, H.M.1    Lee, M.2    Hargreaves, R.3    Pamphilon, D.H.4    Prentice, A.G.5
  • 38
    • 0032873880 scopus 로고    scopus 로고
    • Immune regulation in multiple myeloma: The host-tumour conflict
    • Cook, G. Campbell, J.D. (1999) Immune regulation in multiple myeloma: the host-tumour conflict. Blood Reviews, 13, 151 162
    • (1999) Blood Reviews , vol.13 , pp. 151-162
    • Cook, G.1    Campbell, J.D.2
  • 39
    • 0033454740 scopus 로고    scopus 로고
    • Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes
    • Cook, G., Campbell, J.D., Carr, C.E., Boyd, K.S. Franklin, I.M. (1999) Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes. Journal of Leukocyte Biology, 66, 981 988.
    • (1999) Journal of Leukocyte Biology , vol.66 , pp. 981-988
    • Cook, G.1    Campbell, J.D.2    Carr, C.E.3    Boyd, K.S.4    Franklin, I.M.5
  • 40
    • 0033168605 scopus 로고    scopus 로고
    • Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
    • Corral, L.G., Haslett, P.A., Muller, G.W., Chen, R., Wong, L.M., Ocampo, C.J., Patterson, R.T., Stirling, D.I. Kaplan, G. (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Journal of Immunology, 163, 380 386.
    • (1999) Journal of Immunology , vol.163 , pp. 380-386
    • Corral, L.G.1    Haslett, P.A.2    Muller, G.W.3    Chen, R.4    Wong, L.M.5    Ocampo, C.J.6    Patterson, R.T.7    Stirling, D.I.8    Kaplan, G.9
  • 43
    • 34147144964 scopus 로고    scopus 로고
    • Reduced-intensity conditioning for myeloma: Lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
    • Crawley, C., Iacobelli, S., Bjorkstrand, B., Apperley, J.F., Niederwieser, D. Gahrton, G. (2007) Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. Blood, 109, 3588 3594.
    • (2007) Blood , vol.109 , pp. 3588-3594
    • Crawley, C.1    Iacobelli, S.2    Bjorkstrand, B.3    Apperley, J.F.4    Niederwieser, D.5    Gahrton, G.6
  • 44
    • 0032731377 scopus 로고    scopus 로고
    • Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
    • Cull, G., Durrant, L., Stainer, C., Haynes, A. Russell, N. (1999) Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma. British Journal of Haematology, 107, 648 655.
    • (1999) British Journal of Haematology , vol.107 , pp. 648-655
    • Cull, G.1    Durrant, L.2    Stainer, C.3    Haynes, A.4    Russell, N.5
  • 48
    • 0345599884 scopus 로고    scopus 로고
    • Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy
    • Dhodapkar, M.V., Krasovsky, J., Osman, K. Geller, M.D. (2003b) Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy. Journal of Experimental Medicine, 198, 1753 1757.
    • (2003) Journal of Experimental Medicine , vol.198 , pp. 1753-1757
    • Dhodapkar, M.V.1    Krasovsky, J.2    Osman, K.3    Geller, M.D.4
  • 49
    • 0036889996 scopus 로고    scopus 로고
    • The two faces of IL-6 on Th1/Th2 differentiation
    • Diehl, S. Rincon, M. (2002) The two faces of IL-6 on Th1/Th2 differentiation. Molecular Immunology, 39, 531 536.
    • (2002) Molecular Immunology , vol.39 , pp. 531-536
    • Diehl, S.1    Rincon, M.2
  • 51
    • 0037093854 scopus 로고    scopus 로고
    • Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
    • Dredge, K., Marriott, J.B., Todryk, S.M., Muller, G.W., Chen, R., Stirling, D.I. Dalgleish, A.G. (2002) Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. Journal of Immunology, 168, 4914 4919.
    • (2002) Journal of Immunology , vol.168 , pp. 4914-4919
    • Dredge, K.1    Marriott, J.B.2    Todryk, S.M.3    Muller, G.W.4    Chen, R.5    Stirling, D.I.6    Dalgleish, A.G.7
  • 53
    • 0345365618 scopus 로고    scopus 로고
    • HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
    • Elsasser, D., Valerius, T., Repp, R., Weiner, G.J., Deo, Y., Kalden, J.R., de Winkel, J.G.J., Stevenson, G.T., Glennie, M.J. Gramatzki, M. (1996) HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood, 87, 3803 3812.
    • (1996) Blood , vol.87 , pp. 3803-3812
    • Elsasser, D.1    Valerius, T.2    Repp, R.3    Weiner, G.J.4    Deo, Y.5    Kalden, J.R.6    De Winkel, J.G.J.7    Stevenson, G.T.8    Glennie, M.J.9    Gramatzki, M.10
  • 54
    • 33646477295 scopus 로고    scopus 로고
    • Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma
    • Fauriat, C., Mallet, F., Olive, D. Costello, R.T. (2006) Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma. Leukemia, 20, 732 733.
    • (2006) Leukemia , vol.20 , pp. 732-733
    • Fauriat, C.1    Mallet, F.2    Olive, D.3    Costello, R.T.4
  • 55
    • 0034881738 scopus 로고    scopus 로고
    • Deregulated cytokine network and defective Th1 immune response in multiple myeloma
    • Frassanito, M.A., Cusmai, A. Dammacco, F. (2001) Deregulated cytokine network and defective Th1 immune response in multiple myeloma. Clinical and Experimental Immunology, 125, 190 197.
    • (2001) Clinical and Experimental Immunology , vol.125 , pp. 190-197
    • Frassanito, M.A.1    Cusmai, A.2    Dammacco, F.3
  • 57
    • 0032400862 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
    • Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S. Carbone, D.P. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92, 4150 4166.
    • (1998) Blood , vol.92 , pp. 4150-4166
    • Gabrilovich, D.1    Ishida, T.2    Oyama, T.3    Ran, S.4    Kravtsov, V.5    Nadaf, S.6    Carbone, D.P.7
  • 61
    • 28844462429 scopus 로고    scopus 로고
    • CD8 T-cells specific for cancer-testis antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden
    • Goodyear, O., Piper, K., Khan, N., Starczynski, J., Mahendra, P., Pratt, G. Moss, P. (2005) CD8 T-cells specific for cancer-testis antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden. Blood, 106, 4217 4224.
    • (2005) Blood , vol.106 , pp. 4217-4224
    • Goodyear, O.1    Piper, K.2    Khan, N.3    Starczynski, J.4    Mahendra, P.5    Pratt, G.6    Moss, P.7
  • 62
    • 0036372440 scopus 로고    scopus 로고
    • Transforming growth factor-beta in T-cell biology
    • Gorelik, L. Flavell, R.A. (2002) Transforming growth factor-beta in T-cell biology. Nature Reviews Immunology, 2, 46 53.
    • (2002) Nature Reviews Immunology , vol.2 , pp. 46-53
    • Gorelik, L.1    Flavell, R.A.2
  • 63
    • 33947359949 scopus 로고    scopus 로고
    • Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients
    • Hansson, L., Abdalla, A.O., Moshfegh, A., Choudhury, A., Rabbani, H., Nilsson, B., Osterborg, A. Mellstedt, H. (2007) Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients. Clinical Cancer Research, 13, 1503 1510.
    • (2007) Clinical Cancer Research , vol.13 , pp. 1503-1510
    • Hansson, L.1    Abdalla, A.O.2    Moshfegh, A.3    Choudhury, A.4    Rabbani, H.5    Nilsson, B.6    Osterborg, A.7    Mellstedt, H.8
  • 64
    • 24944449622 scopus 로고    scopus 로고
    • Immunotherapy in multiple myeloma-possibility or probability?
    • Harrison, S.J. Cook, G. (2005) Immunotherapy in multiple myeloma-possibility or probability? British Journal of Haematology, 130, 344 362.
    • (2005) British Journal of Haematology , vol.130 , pp. 344-362
    • Harrison, S.J.1    Cook, G.2
  • 65
    • 0030746472 scopus 로고    scopus 로고
    • The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus
    • Haslett, P., Hempstead, M., Seidman, C., Diakun, J., Vasquez, D., Freedman, V.H. Kaplan, G. (1997) The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Research and Human Retroviruses, 13, 1047 1054.
    • (1997) AIDS Research and Human Retroviruses , vol.13 , pp. 1047-1054
    • Haslett, P.1    Hempstead, M.2    Seidman, C.3    Diakun, J.4    Vasquez, D.5    Freedman, V.H.6    Kaplan, G.7
  • 66
    • 0032100486 scopus 로고    scopus 로고
    • Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset
    • Haslett, P.A., Corral, L.G., Albert, M. Kaplan, G. (1998) Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production and cytotoxic responses in the CD8+ subset. Journal of Experimental Medicine, 187, 1885 1892.
    • (1998) Journal of Experimental Medicine , vol.187 , pp. 1885-1892
    • Haslett, P.A.1    Corral, L.G.2    Albert, M.3    Kaplan, G.4
  • 67
    • 0037444106 scopus 로고    scopus 로고
    • Thalidomide and a thalidomide analogue drug costimulate via specific CD8+ T cells in vitro
    • Haslett, P.A., Hanekom, W.A., Muller, G. Kaplan, G. (2003) Thalidomide and a thalidomide analogue drug costimulate via specific CD8+ T cells in vitro. Journal of Infectious disease, 187, 946 955
    • (2003) Journal of Infectious Disease , vol.187 , pp. 946-955
    • Haslett, P.A.1    Hanekom, W.A.2    Muller, G.3    Kaplan, G.4
  • 69
    • 9444287003 scopus 로고    scopus 로고
    • Novel immunosuppressive properties of interleukin-6 in dendritic cells: Inhibition of NF-kappaB binding activity and CCR7 expression
    • Hegde, S., Pahne, J. Smola-Hess, S. (2004) Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J., 18, 1439 1441.
    • (2004) FASEB J. , vol.18 , pp. 1439-1441
    • Hegde, S.1    Pahne, J.2    Smola-Hess, S.3
  • 70
    • 0036433103 scopus 로고    scopus 로고
    • Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells
    • Heijink, I.H., Vellenga, E., Borger, P., Postma, D.S., de Monchy, J.G. Kauffman, H.F. (2002) Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells. Immunology, 107, 316 324.
    • (2002) Immunology , vol.107 , pp. 316-324
    • Heijink, I.H.1    Vellenga, E.2    Borger, P.3    Postma, D.S.4    De Monchy, J.G.5    Kauffman, H.F.6
  • 72
    • 33746361186 scopus 로고    scopus 로고
    • Active immunotherapy of multiple myeloma
    • Houet, L. Veelken, H. (2006) Active immunotherapy of multiple myeloma. European Journal of Cancer, 42, 1653 1660.
    • (2006) European Journal of Cancer , vol.42 , pp. 1653-1660
    • Houet, L.1    Veelken, H.2
  • 74
    • 0023032745 scopus 로고
    • Immunosuppression and infection in multiple myeloma
    • Jacobson, D.R. Zolla-Pazner, S. (1986) Immunosuppression and infection in multiple myeloma. Seminars in Oncology, 13, 282 290.
    • (1986) Seminars in Oncology , vol.13 , pp. 282-290
    • Jacobson, D.R.1    Zolla-Pazner, S.2
  • 75
  • 76
    • 33744465220 scopus 로고    scopus 로고
    • Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors
    • Jego, G., Bataille, R., Geffroy-Luseau, A., Descamps, G. Pellat-Deceunynck, C. (2006) Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia, 20, 1130 1137.
    • (2006) Leukemia , vol.20 , pp. 1130-1137
    • Jego, G.1    Bataille, R.2    Geffroy-Luseau, A.3    Descamps, G.4    Pellat-Deceunynck, C.5
  • 78
    • 0030991936 scopus 로고    scopus 로고
    • Circulating blood B cells in multiple myeloma: Analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial
    • Kay, N.E., Leong, T., Kyle, R.A., Greipp, P., Billadeau, D., Van Ness, B., Bone, N. Oken, M.M. (1997) Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial. Blood, 90, 340 345.
    • (1997) Blood , vol.90 , pp. 340-345
    • Kay, N.E.1    Leong, T.2    Kyle, R.A.3    Greipp, P.4    Billadeau, D.5    Van Ness, B.6    Bone, N.7    Oken, M.M.8
  • 80
    • 0035412356 scopus 로고    scopus 로고
    • Blood levels of immune cells predict survival in myeloma patients: Results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients
    • Kay, N.E., Leong, T.L., Bone, N., Vesole, D.H., Greipp, P.R., Van Ness, B., Oken, M.M. Kyle, R.A. (2001) Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood, 98, 23 28.
    • (2001) Blood , vol.98 , pp. 23-28
    • Kay, N.E.1    Leong, T.L.2    Bone, N.3    Vesole, D.H.4    Greipp, P.R.5    Van Ness, B.6    Oken, M.M.7    Kyle, R.A.8
  • 82
    • 18544390035 scopus 로고    scopus 로고
    • Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis
    • Koh, K.R., Janz, M., Mapara, M.Y., Lemke, B., Stirling, D., Dorken, B., Zenke, M. Lentzsch, S. (2005) Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis. Blood, 105, 3833 3840.
    • (2005) Blood , vol.105 , pp. 3833-3840
    • Koh, K.R.1    Janz, M.2    Mapara, M.Y.3    Lemke, B.4    Stirling, D.5    Dorken, B.6    Zenke, M.7    Lentzsch, S.8
  • 83
    • 0034660687 scopus 로고    scopus 로고
    • Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
    • Kunzmann, B., Bauer, E., Feurle, J., Weissinger, F., Tony, H.P. Wilhelm, M. (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96, 384 392.
    • (2000) Blood , vol.96 , pp. 384-392
    • Kunzmann, B.1    Bauer, E.2    Feurle, J.3    Weissinger, F.4    Tony, H.P.5    Wilhelm, M.6
  • 84
    • 33747480248 scopus 로고    scopus 로고
    • Monoclonal gammopathy of undetermined significance
    • Kyle, R.A. Rajkumar, S.V. (2006) Monoclonal gammopathy of undetermined significance. British Journal of Haematology, 134, 573 589.
    • (2006) British Journal of Haematology , vol.134 , pp. 573-589
    • Kyle, R.A.1    Rajkumar, S.V.2
  • 85
    • 33845953091 scopus 로고    scopus 로고
    • Respiratory tract infections in the pathway to multiple myeloma: A population-based study in Scandinavia
    • Landgren, O., Rapkin, J.S., Mellemkjaer, L., Gridley, G., Goldin, L.R. Engels, E.A. (2006) Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica, 91, 1697 1700.
    • (2006) Haematologica , vol.91 , pp. 1697-1700
    • Landgren, O.1    Rapkin, J.S.2    Mellemkjaer, L.3    Gridley, G.4    Goldin, L.R.5    Engels, E.A.6
  • 88
    • 0032834303 scopus 로고    scopus 로고
    • Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
    • Lim, S.H. Bailey-Wood, R. (1999) Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. International Journal of Cancer, 83, 215 222.
    • (1999) International Journal of Cancer , vol.83 , pp. 215-222
    • Lim, S.H.1    Bailey-Wood, R.2
  • 91
    • 33847079661 scopus 로고    scopus 로고
    • B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro
    • Lu, Z.Y., Condomines, M., Tarte, K., Nadal, L., Delteil, M.C., Rossi, J.F., Ferrand, C. Klein, B. (2007) B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro. Experimental Hematology, 35, 443 453.
    • (2007) Experimental Hematology , vol.35 , pp. 443-453
    • Lu, Z.Y.1    Condomines, M.2    Tarte, K.3    Nadal, L.4    Delteil, M.C.5    Rossi, J.F.6    Ferrand, C.7    Klein, B.8
  • 94
    • 0034945969 scopus 로고    scopus 로고
    • Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion
    • Mariani, S., Coscia, M., Even, J., Peola, S., Foglietta, M., Boccadoro, M., Sbaiz, L., Restagno, G., Pileri, A. Massaia, M. (2001) Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. British Journal of Haematology, 113, 1051 1059.
    • (2001) British Journal of Haematology , vol.113 , pp. 1051-1059
    • Mariani, S.1    Coscia, M.2    Even, J.3    Peola, S.4    Foglietta, M.5    Boccadoro, M.6    Sbaiz, L.7    Restagno, G.8    Pileri, A.9    Massaia, M.10
  • 96
    • 0036381106 scopus 로고    scopus 로고
    • Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells
    • Marriott, J.B., Clarke, I.A., Dredge, K., Muller, G., Stirling, D. Dalgleish, A.G. (2002) Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells. Clinical and Experimental Immunology, 130, 75 84.
    • (2002) Clinical and Experimental Immunology , vol.130 , pp. 75-84
    • Marriott, J.B.1    Clarke, I.A.2    Dredge, K.3    Muller, G.4    Stirling, D.5    Dalgleish, A.G.6
  • 98
    • 0020673510 scopus 로고
    • Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: Relationship to treatment and clinical stage
    • Mills, K.H. Cawley, J.C. (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. British Journal of Haematology, 53, 271 275.
    • (1983) British Journal of Haematology , vol.53 , pp. 271-275
    • Mills, K.H.1    Cawley, J.C.2
  • 99
    • 33749439349 scopus 로고    scopus 로고
    • MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
    • Molle, I., Peterslund, N.A., Thiel, S. Steffensen, R. (2006) MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation, 38, 555 560.
    • (2006) Bone Marrow Transplantation , vol.38 , pp. 555-560
    • Molle, I.1    Peterslund, N.A.2    Thiel, S.3    Steffensen, R.4
  • 102
    • 1642348866 scopus 로고    scopus 로고
    • Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization
    • Mor, F., Quintana, F.J. Cohen, I.R. (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. Journal of Immunology, 172, 4618 4623.
    • (2004) Journal of Immunology , vol.172 , pp. 4618-4623
    • Mor, F.1    Quintana, F.J.2    Cohen, I.R.3
  • 104
    • 0029966625 scopus 로고    scopus 로고
    • Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia
    • Moss, P., Gillespie, G., Frodsham, P., Bell, J. Reyburn, H. (1996) Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. Blood, 87, 3297 3306.
    • (1996) Blood , vol.87 , pp. 3297-3306
    • Moss, P.1    Gillespie, G.2    Frodsham, P.3    Bell, J.4    Reyburn, H.5
  • 106
    • 0036175389 scopus 로고    scopus 로고
    • Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells
    • Nagy, M., Chapuis, B. Matthes, T. (2002) Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells. British Journal of Haematology, 116, 429 435.
    • (2002) British Journal of Haematology , vol.116 , pp. 429-435
    • Nagy, M.1    Chapuis, B.2    Matthes, T.3
  • 109
    • 33749647652 scopus 로고    scopus 로고
    • Cancer immunotherapy is more than a numbers game
    • Offringa, R. (2006) Cancer immunotherapy is more than a numbers game. Science, 314, 68 69.
    • (2006) Science , vol.314 , pp. 68-69
    • Offringa, R.1
  • 112
    • 0030175914 scopus 로고    scopus 로고
    • Prophylactic antibiotics for the prevention of early infection in multiple myeloma
    • Oken, M., Pomeroy, C., Weisdorf, D. Bennett, J. (1996) Prophylactic antibiotics for the prevention of early infection in multiple myeloma. American Journal of Medicine, 100, 624 628.
    • (1996) American Journal of Medicine , vol.100 , pp. 624-628
    • Oken, M.1    Pomeroy, C.2    Weisdorf, D.3    Bennett, J.4
  • 113
    • 0032055911 scopus 로고    scopus 로고
    • Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses
    • Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jedi-Tehrani, M., Ruden, U., Lefvert, A.K., Holm, G. Mellstedt, H. (1998) Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood, 91, 2459 2466.
    • (1998) Blood , vol.91 , pp. 2459-2466
    • Osterborg, A.1    Yi, Q.2    Henriksson, L.3    Fagerberg, J.4    Bergenbrant, S.5    Jedi-Tehrani, M.6    Ruden, U.7    Lefvert, A.K.8    Holm, G.9    Mellstedt, H.10
  • 116
    • 10344264979 scopus 로고    scopus 로고
    • Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner
    • Payvandi, F., Wu, L., Haley, M., Schafer, P.H., Zhang, L.H., Chen, R.S., Muller, G.W. Stirling, D.I. (2004) Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner. Cellular Immunology, 230, 81 88.
    • (2004) Cellular Immunology , vol.230 , pp. 81-88
    • Payvandi, F.1    Wu, L.2    Haley, M.3    Schafer, P.H.4    Zhang, L.H.5    Chen, R.S.6    Muller, G.W.7    Stirling, D.I.8
  • 117
    • 27244451493 scopus 로고    scopus 로고
    • Co-stimulatory pathways in lymphocyte regulation: The immunoglobulin superfamily
    • Peggs, K.S. Allison, J.P. (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. British Journal of Haematology, 130, 809 824.
    • (2005) British Journal of Haematology , vol.130 , pp. 809-824
    • Peggs, K.S.1    Allison, J.P.2
  • 119
    • 33644847914 scopus 로고    scopus 로고
    • Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire
    • Pérez-Andres, M., Almeida, J., Martin-Ayuso, M., Moro, M.J., Martin-Nuñez, G., Galende, J., Hernandez, J., Mateo, G., San Miguel, J.F. Orfao, A. (2006) Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Cancer, 106, 1296 1305.
    • (2006) Cancer , vol.106 , pp. 1296-1305
    • Pérez-Andres, M.1    Almeida, J.2    Martin-Ayuso, M.3    Moro, M.J.4    Martin-Nuñez, G.5    Galende, J.6    Hernandez, J.7    Mateo, G.8    San Miguel, J.F.9    Orfao, A.10
  • 120
    • 0019825038 scopus 로고
    • Influence of treatment and response status on infection risk in multiple myeloma
    • Perri, R.T., Hebbel, R.P. Oken, M.M. (1981) Influence of treatment and response status on infection risk in multiple myeloma. American Journal of Medicine, 71, 935 940.
    • (1981) American Journal of Medicine , vol.71 , pp. 935-940
    • Perri, R.T.1    Hebbel, R.P.2    Oken, M.M.3
  • 122
    • 13544255403 scopus 로고    scopus 로고
    • The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications
    • Podar, K. Anderson, K.C. (2005) The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood, 105, 383 1395.
    • (2005) Blood , vol.105 , pp. 383-1395
    • Podar, K.1    Anderson, K.C.2
  • 126
    • 33750565570 scopus 로고    scopus 로고
    • Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: Could it be beneficial in early disease?
    • Prutchi-Sagiv, S., Golishevsky, N., Oster, H.S., Katz, O., Cohen, A., Naparstek, E., Neumann, D. Mittelman, M. (2006) Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? British Journal of Haematology, 135, 660 672.
    • (2006) British Journal of Haematology , vol.135 , pp. 660-672
    • Prutchi-Sagiv, S.1    Golishevsky, N.2    Oster, H.S.3    Katz, O.4    Cohen, A.5    Naparstek, E.6    Neumann, D.7    Mittelman, M.8
  • 131
    • 0037804767 scopus 로고    scopus 로고
    • Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells
    • Rasmussen, T., Hansson, L., Österborg, A., Johnsen, H.E. Mellstedt, H. (2003) Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells. Blood, 101, 4607 4610.
    • (2003) Blood , vol.101 , pp. 4607-4610
    • Rasmussen, T.1    Hansson, L.2    Österborg, A.3    Johnsen, H.E.4    Mellstedt, H.5
  • 133
    • 0031961959 scopus 로고    scopus 로고
    • B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors
    • Rawstron, A.C., Davies, F.E., Owen, R.G., English, A., Pratt, G., Child, J.A., Jack, A.S. Morgan, G.J. (1998) B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. British Journal of Haematology, 100, 176 183.
    • (1998) British Journal of Haematology , vol.100 , pp. 176-183
    • Rawstron, A.C.1    Davies, F.E.2    Owen, R.G.3    English, A.4    Pratt, G.5    Child, J.A.6    Jack, A.S.7    Morgan, G.J.8
  • 134
    • 0025859580 scopus 로고
    • Perspectives in multiple myeloma survival, prognostic factors and disease complications in a single centre between 1975 and 1988
    • Rayner, H.C., Haynes, A.P., Thompson, J.R., Russell, N. Fletcher, J. (1991). Perspectives in multiple myeloma survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Quarterly Journal of Medicine, 79, 517 525.
    • (1991) Quarterly Journal of Medicine , vol.79 , pp. 517-525
    • Rayner, H.C.1    Haynes, A.P.2    Thompson, J.R.3    Russell, N.4    Fletcher, J.5
  • 135
    • 0033120389 scopus 로고    scopus 로고
    • Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
    • Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G. Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - a feasibility study. Blood, 93, 2411 2419.
    • (1999) Blood , vol.93 , pp. 2411-2419
    • Reichardt, V.L.1    Okada, C.Y.2    Liso, A.3    Benike, C.J.4    Stockerl-Goldstein, K.E.5    Engleman, E.G.6    Blume, K.G.7    Levy, R.8
  • 136
    • 0242330773 scopus 로고    scopus 로고
    • Idiotype vaccination of multiple myeloma zpatients using monocyte-derived dendritic cells
    • Reichardt, V.L., Milazzo, C., Brugger, W., Einsele, H., Kanz, L. Brossart, P. (2003) Idiotype vaccination of multiple myeloma zpatients using monocyte-derived dendritic cells. Haematologica, 88, 1139 1149.
    • (2003) Haematologica , vol.88 , pp. 1139-1149
    • Reichardt, V.L.1    Milazzo, C.2    Brugger, W.3    Einsele, H.4    Kanz, L.5    Brossart, P.6
  • 137
    • 0035525742 scopus 로고    scopus 로고
    • Persistent preswitch clonotypic myeloma cells correlate with decreased survival: Evidence for isotype switching within the myeloma clone
    • Reiman, T., Seeberger, K., Taylor, B.J., Szczepek, A.J., Hanson, J., Mant, M.J., Coupland, R.W., Belch, A.R. Pilarski, L.M. (2001) Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone. Blood, 98, 2791 2799.
    • (2001) Blood , vol.98 , pp. 2791-2799
    • Reiman, T.1    Seeberger, K.2    Taylor, B.J.3    Szczepek, A.J.4    Hanson, J.5    Mant, M.J.6    Coupland, R.W.7    Belch, A.R.8    Pilarski, L.M.9
  • 140
    • 0034017680 scopus 로고    scopus 로고
    • Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
    • Robertson, J.D., Nagesh, K., Jowitt, S.N., Dougal, M., Anderson, H., Mutton, K., Zambon, M. Scarffe, J.H. (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. British Journal of Cancer, 82, 1261 1265.
    • (2000) British Journal of Cancer , vol.82 , pp. 1261-1265
    • Robertson, J.D.1    Nagesh, K.2    Jowitt, S.N.3    Dougal, M.4    Anderson, H.5    Mutton, K.6    Zambon, M.7    Scarffe, J.H.8
  • 143
    • 0026080801 scopus 로고
    • Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
    • Sampaio, E.P., Sarno, E.N., Galilly, R., Cohn, Z.A. Kaplan, G. (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. Journal of Experimental Medicine, 173, 699 703.
    • (1991) Journal of Experimental Medicine , vol.173 , pp. 699-703
    • Sampaio, E.P.1    Sarno, E.N.2    Galilly, R.3    Cohn, Z.A.4    Kaplan, G.5
  • 144
    • 20044395957 scopus 로고    scopus 로고
    • Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma
    • Sanderson, K., Scotland, R., Lee, P., Liu, D., Groshen, S., Snively, J., Sian, S., Nichol, G., Davis, T., Keler, T., Yellin, M. Weber, J. (2005) Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. Journal of Clinical Oncology, 23, 741 750.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 741-750
    • Sanderson, K.1    Scotland, R.2    Lee, P.3    Liu, D.4    Groshen, S.5    Snively, J.6    Sian, S.7    Nichol, G.8    Davis, T.9    Keler, T.10    Yellin, M.11    Weber, J.12
  • 148
    • 33644869566 scopus 로고    scopus 로고
    • Guidelines on the diagnosis and management of multiple myeloma 2005
    • Smith, A., Wisloff, F. Samson, D. (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. British Journal of Haematology, 132, 410 451.
    • (2006) British Journal of Haematology , vol.132 , pp. 410-451
    • Smith, A.1    Wisloff, F.2    Samson, D.3
  • 150
    • 33748189347 scopus 로고    scopus 로고
    • Cell-surface association between matrix metalloproteinases and integrins: Role of the complexes in leukocyte migration and cancer progression
    • Stefanidakis, M. Koivunen, E. (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood, 108, 1441 1450.
    • (2006) Blood , vol.108 , pp. 1441-1450
    • Stefanidakis, M.1    Koivunen, E.2
  • 152
    • 0032531999 scopus 로고    scopus 로고
    • A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR
    • Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR. Blood, 92, 2844 2855.
    • (1998) Blood , vol.92 , pp. 2844-2855
    • Szczepek, A.J.1    Seeberger, K.2    Wizniak, J.3    Mant, M.J.4    Belch, A.R.5    Pilarski, L.M.6
  • 154
    • 2542470851 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines
    • Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H. Matsumoto, Y. (2004) Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunology, Immunotherapy, 53, 543 550.
    • (2004) Cancer Immunology, Immunotherapy , vol.53 , pp. 543-550
    • Takahashi, A.1    Kono, K.2    Ichihara, F.3    Sugai, H.4    Fujii, H.5    Matsumoto, Y.6
  • 155
    • 27444433159 scopus 로고    scopus 로고
    • SSX cancer testis antigens are expressed in most multiple myeloma patients: Co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs
    • Taylor, B.J., Reiman, T., Pittman, J.A., Keats, J.J., de Bruin, D.R., Mant, M.J., Belch, A.R. Pilarski, L.M. (2005) SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. Journal of Immunotherapy, 28, 564 575.
    • (2005) Journal of Immunotherapy , vol.28 , pp. 564-575
    • Taylor, B.J.1    Reiman, T.2    Pittman, J.A.3    Keats, J.J.4    De Bruin, D.R.5    Mant, M.J.6    Belch, A.R.7    Pilarski, L.M.8
  • 156
    • 27644457376 scopus 로고    scopus 로고
    • TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
    • Thomas, D.A. Massague, J. (2005) TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell, 8, 369 380.
    • (2005) Cancer Cell , vol.8 , pp. 369-380
    • Thomas, D.A.1    Massague, J.2
  • 157
    • 30444431620 scopus 로고    scopus 로고
    • Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway
    • Thompson, K., Rojas-Navea, J. Rogers, M.J. (2006) Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood, 107, 651 654.
    • (2006) Blood , vol.107 , pp. 651-654
    • Thompson, K.1    Rojas-Navea, J.2    Rogers, M.J.3
  • 161
    • 0030959255 scopus 로고    scopus 로고
    • Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance
    • Villunger, A., Egle, A., Marschitz, I., Kos, M., Böck, G., Ludwig, H., Geley, S., Kofler, R. Greil, R. (1997) Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood, 90, 12 20.
    • (1997) Blood , vol.90 , pp. 12-20
    • Villunger, A.1    Egle, A.2    Marschitz, I.3    Kos, M.4    Böck, G.5    Ludwig, H.6    Geley, S.7    Kofler, R.8    Greil, R.9
  • 163
    • 33644757687 scopus 로고    scopus 로고
    • Tumor evasion of the immune system: Inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
    • Wang, S., Yang, J., Qian, J., Wezeman, W., Kwak, L. Yi, Q. (2006a) Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood, 107, 2432 2439.
    • (2006) Blood , vol.107 , pp. 2432-2439
    • Wang, S.1    Yang, J.2    Qian, J.3    Wezeman, W.4    Kwak, L.5    Yi, Q.6
  • 164
    • 33845482670 scopus 로고    scopus 로고
    • Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
    • Wang, S., Hong, S., Yang, J., Qian, J., Zhang, X., Shpall, E., Kwak, L.W. Yi, Q. (2006b) Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood, 108, 4071 4077.
    • (2006) Blood , vol.108 , pp. 4071-4077
    • Wang, S.1    Hong, S.2    Yang, J.3    Qian, J.4    Zhang, X.5    Shpall, E.6    Kwak, L.W.7    Yi, Q.8
  • 165
    • 33748940534 scopus 로고    scopus 로고
    • Lenalidomide plus high-dose dexamethasone provides improved overall survival compared to high-dose dexamethasone alone for relapsed or refractory multiple myeloma (MM): Results of a North American phase III study (MM-009)
    • Abstract 7521.
    • Weber, D.M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E., YuZ Olesnyckyj, M., Zeldis, J. Knight, R. (2006) Lenalidomide plus high-dose dexamethasone provides improved overall survival compared to high-dose dexamethasone alone for relapsed or refractory multiple myeloma (MM): Results of a North American phase III study (MM-009). Journal of Clinical Oncology, 24, Abstract 7521.
    • (2006) Journal of Clinical Oncology , vol.24
    • Weber, D.M.1    Chen, C.2    Niesvizky, R.3    Wang, M.4    Belch, A.5    Stadtmauer, E.6    Yuz Olesnyckyj, M.7    Zeldis, J.8    Knight, R.9
  • 166
    • 0035869383 scopus 로고    scopus 로고
    • Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: Evidence for their capacity to lyse autologous primary tumor cells
    • Wen, Y.J., Barlogie, B. Yi, Q. (2001) Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood, 97, 1750 1755.
    • (2001) Blood , vol.97 , pp. 1750-1755
    • Wen, Y.J.1    Barlogie, B.2    Yi, Q.3
  • 169
    • 0038264409 scopus 로고    scopus 로고
    • Beta 2-microglobulin as a negative regulator of the immune system: High concentrations of the protein inhibit in vitro generation of functional dendritic cells
    • Xie, J., Ying, W., Freeman, M.E., Barlogie, B. Qing, Y. (2003) Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells. Blood, 101, 4005 4012.
    • (2003) Blood , vol.101 , pp. 4005-4012
    • Xie, J.1    Ying, W.2    Freeman, M.E.3    Barlogie, B.4    Qing, Y.5
  • 170
    • 0028875568 scopus 로고
    • Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies
    • Yi, Q., Osterborg, A., Bergenbrant, S., Mellstedt, H., Holm, G. Lefvert, A.K. (1995) Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood, 86, 3043 3049.
    • (1995) Blood , vol.86 , pp. 3043-3049
    • Yi, Q.1    Osterborg, A.2    Bergenbrant, S.3    Mellstedt, H.4    Holm, G.5    Lefvert, A.K.6
  • 171
    • 0030884240 scopus 로고    scopus 로고
    • Myeloma bone marrow plasma cells: Evidence for their capacity as antigen-presenting cells
    • Yi, Q., Dabadghao, S., Osterborg, A., Bergenbrant, S. Holm, G. (1997) Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells. Blood, 90, 1960 1967.
    • (1997) Blood , vol.90 , pp. 1960-1967
    • Yi, Q.1    Dabadghao, S.2    Osterborg, A.3    Bergenbrant, S.4    Holm, G.5
  • 172
  • 173
    • 33745125857 scopus 로고    scopus 로고
    • Intranodal vaccination with idiotype-pulsed dendritic cells induces potent and long lasting cellular and humoral immune responses in myeloma patients
    • Abstract 5277.
    • Yi, Q., Freeman, M.E., Szmania, S., Rosen, N., Cottler-Fox, M., Barlogie, B., Tricot, G. van Rhee, F. (2003) Intranodal vaccination with idiotype-pulsed dendritic cells induces potent and long lasting cellular and humoral immune responses in myeloma patients. Blood, 102 (Suppl. 1 Abstract 5277.
    • (2003) Blood , vol.102 , Issue.1
    • Yi, Q.1    Freeman, M.E.2    Szmania, S.3    Rosen, N.4    Cottler-Fox, M.5    Barlogie, B.6    Tricot, G.7    Van Rhee, F.8
  • 174
    • 0000343858 scopus 로고
    • Recurrent pneumonia in multiple myeloma and some observations on immunologic response
    • Zinneman, H.H. Hall, W.H. (1954) Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Annals of Internal Medicine, 41, 1152 1163.
    • (1954) Annals of Internal Medicine , vol.41 , pp. 1152-1163
    • Zinneman, H.H.1    Hall, W.H.2
  • 175
    • 33748987908 scopus 로고    scopus 로고
    • Cancer despite immunosurveillance: Immunoselection and immunosubversion
    • Zitvogel, L., Tesniere, A. Kroemer, G. (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nature Reviews Immunology, 6, 715 727.
    • (2006) Nature Reviews Immunology , vol.6 , pp. 715-727
    • Zitvogel, L.1    Tesniere, A.2    Kroemer, G.3
  • 176
    • 16844379997 scopus 로고    scopus 로고
    • Immunosuppressive networks in the tumour environment and their therapeutic relevance
    • Zou W. (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer, 5, 263 274.
    • (2005) Nature Reviews Cancer , vol.5 , pp. 263-274
    • Zou, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.